Outcomes following second allogeneic stem cell transplant for disease relapse after T cell depleted transplant correlate with remission status and remission duration after the first transplant

Table 1 Characteristics of the patients

Variable	Total
Total patients	65
Median Age (range)	45 (11–73)
Male/female	48/17
Diagnosis
AML	47
MDS	5
Lymphoma	6
CML	2
Other leukemia	5
Disease status before second HCT
Remission	13
Not in remission	52
Donor status
MRD	33
MUD	21
Haplo-cord	11
Conditioning regimen for first HCT
Myeloablative	19
RIC	46
Conditioning regimen for second HCT
Myeloablative	44
Flu-Bu-Alemtuzumab	18
TBI-based	7
Bu/Cy	7
RIC	21
Flu-mel-Alemtuzumab	5
Clo-mel-Alemtuzumab	7
Flu-mel-ATG	7

MRD matched related donor, MUD matched unrelated donor, MDS myelodysplastic syndrome